Centre Hospitalier Universitaire de Brugmann

The Centre Hospitalier Universitaire de Brugmann (CHU Brugmann) — also known as Brugmann University Hospital — is one of the leading public university hospitals in the Brussels Capital Region of Belgium. With 858 beds, approximately 27,000 inpatient admissions, and over 280,000 outpatient clinic consultations each year, CHU Brugmann plays a central role in healthcare provision for Brussels and its diverse, multicultural population.

CHU Brugmann is affiliated with two of Belgium's principal universities: the Université Libre de Bruxelles (ULB) and the Vrije Universiteit Brussel (VUB). This dual affiliation reflects Brussels' bilingual French-Dutch character and ensures that the hospital serves both French-speaking and Dutch-speaking communities of the capital. The university connection drives a strong culture of clinical research, evidence-based practice, and specialist physician training across the hospital's many departments.

The hospital operates across three complementary sites in Brussels, each with its own specialist focus and catchment area, allowing it to provide both broad general medical services and subspecialised tertiary care. CHU Brugmann is a member of the IRIS network — the public hospital consortium of the Brussels Capital Region — and adheres to the IRIS patient charter, which guarantees the rights of patients to respectful, non-discriminatory, high-quality care.

One of the hospital's distinctive architectural features is its pavilion structure, which separates medical departments across low-rise buildings within a campus setting. This design — rare in modern European healthcare — contributes to a less clinical atmosphere than many large hospitals and promotes patient comfort. Continuous architectural investment ensures that these historical buildings meet the technical requirements of twenty-first century medicine.

CHU Brugmann offers a broad and comprehensive range of medical and surgical specialties typical of a major university hospital. As a teaching and research institution, its clinical departments are closely linked to ULB and VUB medical faculties, providing patients with access to the latest evidence-based treatments and clinical trials.

Cardiology and heart surgery form a cornerstone of the hospital's clinical programme, with services spanning diagnostic cardiology, coronary intervention, electrophysiology, cardiac imaging, and complex cardiac surgery. Hemato-oncology manages blood cancers and coordinates solid tumour care through multidisciplinary tumour boards.

Emergency medicine and critical care are among the hospital's highest-volume services, with 24-hour emergency reception and intensive care capacity to manage acute medical, surgical, and trauma presentations. Neurology covers stroke, epilepsy, and neurodegenerative conditions, complemented by psychiatry services. Gynaecology and obstetrics include high-risk maternity care with neonatal intensive care support.

Other departments include gastroenterology, endocrinology, geriatrics, nephrology with dialysis, rheumatology, pneumology, orthopaedics and traumatology, urology, ophthalmology, dermatology, plastic surgery, stomatology, immuno-allergology, otorhinolaryngology (ENT), paediatrics, neonatology, nuclear medicine with radioisotopes, anaesthesiology, anatomopathology and cytogenetics, radiology, and clinical biology. The breadth of this specialist provision reflects the hospital's status as a major academic medical centre.

CHU Brugmann operates from its multi-site Brussels campus with a total capacity of 858 licensed beds across general wards, intensive care, coronary care, neonatal intensive care, and day surgery facilities. The hospital's pavilion structure spreads departments across purpose-designed buildings, providing each specialty with dedicated space while sharing centralised support services.

Operating theatres are fully equipped for cardiac, orthopaedic, neurosurgical, gynaecological, plastic, and general surgical procedures. Laparoscopic and minimally invasive surgery equipment enables complex abdominal and thoracic procedures with reduced patient recovery times. The anaesthesiology department supports both elective and emergency operations across multiple theatres simultaneously.

The radiology and medical imaging department provides digital X-ray, multi-slice CT, MRI, ultrasound, interventional radiology, nuclear medicine, and radioisotope therapy. The anatomopathology and cytogenetics laboratory handles tissue, cytology, and genetic analysis supporting cancer diagnosis, prenatal testing, and rare disease investigation.

Clinical biology processes haematological, biochemical, microbiological, and immunological investigations supporting all inpatient and outpatient services. The hospital pharmacy manages routine dispensing, clinical pharmacy support, and specialised chemotherapy compounding. The one-day clinic facilitates ambulatory treatments, minor procedures, and diagnostic investigations without overnight admission, reducing waiting times and optimising bed use.

CHU Brugmann's location in Brussels — the seat of the European Union institutions and NATO headquarters — means that international patients, European civil servants, diplomats, and expatriates form a substantial part of its patient population. The hospital is well experienced in providing care to non-Belgian nationals across a wide range of clinical specialties.

As a bilingual institution linked to both French-speaking ULB and Dutch-speaking VUB, the hospital operates fluently in both French and Dutch. Given Brussels' cosmopolitan character, English is also widely used by clinical staff. The hospital's administrative teams located at Place Arthur Van Gehuchten 4, Brussels (Laeken), can assist international patients with appointment scheduling, medical record requests, and insurance documentation.

Brussels is one of Europe's most connected cities, served by Brussels Airport (Zaventem) with direct flights to most major international destinations, as well as high-speed Thalys and Eurostar rail services to Paris, London, Amsterdam, and Cologne. The hospital's sites are accessible by the Brussels Metro and public transport network.

EU citizens benefit from full cross-border healthcare rights under EU Directive 2011/24/EU, including the right to receive elective treatment in Belgium and seek reimbursement from their home country health insurance. Non-EU patients and those requiring private billing should contact the hospital's medical direction office in advance to obtain cost estimates and arrange prior authorisation. Emergency patients receive immediate care regardless of insurance status under the IRIS patient charter.

CHU Brugmann is accredited and regulated as a public university hospital under Belgian federal law and Brussels Capital Region healthcare regulations. As a member of the IRIS public hospital network, the hospital is subject to the Brussels regional government's quality oversight framework and adheres to the IRIS patient charter.

The hospital's dual affiliation with ULB and VUB carries university hospital accreditation requirements, including obligations to provide specialist physician training across a broad range of disciplines, conduct clinical and translational research, and maintain the clinical volumes and infrastructure necessary to support academic medicine.

Belgian hospitals report quality and safety indicators to the National Institute for Health and Disability Insurance (NIHDI / RIZIV), covering clinical outcomes, safety events, infection rates, medication errors, and patient satisfaction. This national reporting framework enables benchmarking against peer institutions and drives continuous quality improvement.

CHU Brugmann participates in national and European clinical research networks, bringing new treatments and diagnostic approaches into clinical practice. Its adherence to the patient charter framework ensures that all patients — regardless of nationality, insurance status, or social background — receive care that meets defined minimum standards of quality and dignity.